Filtered By:
Therapy: Pain Management

This page shows you your search results in order of date.

Order by Relevance | Date

Total 61 results found since Jan 2013.

The Macro View – Health, Economics, and Politics and the Big Picture. What I Am Watching Here And Abroad.
 September 08, 2022 Edition-----In the US we are seeing the outcomes of Climate Change really of and running with droughts and fires etc. Biden amped up the partisan divide with a fiery anti-Republican speech!In Russia the last leader of Soviet Russia died.In the UK we have a new PM while in Europe the energy crisis is just getting worse.In OZ we have survived the Jobs and Skills Summit with 36 prearranged outcomes. Stage management +++ in action. The GP crisis is not being addressed fully and worries regarding the Global Economy - esp. China - worsen.-----Major Issues.-----https://www.afr.com/work-and-careers/educati...
Source: Australian Health Information Technology - September 8, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Spinal cord stimulation for treatment of complex regional pain syndrome: a single-centre retrospective case series study
CONCLUSIONS AND CLINICAL IMPLICATIONS: SCS is the best alternative for patients with CRPS. It should be used immediately after the failure of conservative treatment. Despite the relatively high complication rate in our series, it is the best choice for pain reduction management in this select group of patients.PMID:35722899 | DOI:10.5603/PJNNS.a2022.0038
Source: Neurologia i Neurochirurgia Polska - June 20, 2022 Category: Neurology Authors: Marek Prokopienko Micha ł Sobstyl Source Type: research

It ’ s time for a change
Much has been written about the challenges frontline health care workers have faced during the COVID-19 pandemic. Long hours, excessive death, and fear for one’s own safety and the welfare of family and colleagues have been a consistent theme over the past 22 months. Physicians and nurses started as heroes, but due to strained politics and social-media misuse, they’re now branded by a substantial swath of society as pariahs and purveyors of a medical hoax. The timing of this pandemic could not have been worse: According to the Medscape National Physician Burnout & Suicide Report 2021, 79% of physicians stated their...
Source: The Hospitalist - March 1, 2022 Category: Hospital Management Authors: Ronda Whitaker Tags: Business of Medicine COVID-19 Hospital Medicine Practice Management Source Type: research

Leadership Mindset with an Emphasis in EMS, Part Three
Conclusion “Half of what is taught in medical school is wrong, but nobody knows which half. –  Lucy Hornstein, MD.”15 The same could be said about leadership as well. Many leadership fads have been developed over time and may have had their place, but as times and trends change, so does leadership. As leaders in EMS, it’s crucial to adapt to the new generations of employees and identifying the best ways to work for and with them. The story of the blind men and the elephant is a good story to remember as leaders to say not all things that appear to be true necessarily are.    ...
Source: JEMS Patient Care - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Administration and Leadership Exclusives Adminstration & Leadership EMS Source Type: news

Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder.
CONCLUSION: The need to increase the number of patients receiving MOUD led to the implementation of a CPCM model. The program was effectively implemented into practice and expanded the availability of MOUD, which allowed patients to access treatment in multiple care settings. PMID: 33326564 [PubMed - as supplied by publisher]
Source: American Journal of Health-System Pharmacy : AJHP - December 16, 2020 Category: Drugs & Pharmacology Authors: DeRonne BM, Wong KR, Schultz E, Jones E, Krebs EE Tags: Am J Health Syst Pharm Source Type: research

Network meta-analysis to compare VenaSeal with other superficial venous therapies for chronic venous insufficiency
ConclusionsVenaSeal system is a promising therapeutic option for anatomic success at 6 months, with fewer occurrences of adverse events (wound and groin infection, pulmonary embolism) in CVI patients compared with other interventions in this study. Additional economic analysis including cost-effectiveness analysis would provide interesting perspectives on real-world insights to patients, payers, and providers.
Source: Journal of Vascular Surgery: Venous and Lymphatic Disorders - February 14, 2020 Category: Surgery Source Type: research

High-Sensitivity Troponin is not a Myth, and “Myth-busting” is often another Myth to be Busted
Conclusion: Early rule out protocol is effective and safe.We refer interested readers to the following excellent reviews of high-sensitivity troponin implementation:Twerenbold, R. et al.JACC70 (8): 996 –1012.https://doi.org/10.1016/j.jacc.2017.07.718.Yader S. et al. 2016. Am J Med 129 (4): 354 –65.https://doi.org/10.1016/j.amjmed.2015.12.005.Response to the 2nd “Myth-busting” articleInterestingly, on Nov 5, Dr. Spiegel publishedanother “Myths in EM” piece in EM News: “Is hs-cTnT Worth the Downstream Testing?. The piece assesses a new randomized trial of the Roche hs -cTnT (not the Abbott Troponin I,...
Source: Dr. Smith's ECG Blog - November 9, 2019 Category: Cardiology Authors: Steve Smith Source Type: blogs

Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF- β
This study was carried out in accordance with approval of the Melbourne Health and Walter and Eliza Hall Institute of Medical Research's Human Research Ethics Committee (approval number: 2013.081). All subjects gave written informed consent for participation and publication. Results and Discussion TGF-β signaling in NK cells is associated with: phosphorylation in SMAD2 and 3, inhibition of IL-15-induced metabolism/proliferation, simultaneous downregulation of CD44, CD49e, and Eomes, and upregulation of CD16 and CD49a expression (7, 10). SMAD family member 4 (SMAD4) belongs to the SMAD family of transcript...
Source: Frontiers in Immunology - April 30, 2019 Category: Allergy & Immunology Source Type: research

Finally, a Wearable Neuromodulation Device for Overactive Bladder
As a urogynecology surgeon, Alexandra Haessler, MD, has seen firsthand the limitations of current overactive bladder (OAB) therapies. Aside from medication, the current gold standard for OAB is Medtronic's InterStim, an implantable sacral neuromodulation device that is FDA approved for the treatment of OAB as well as chronic fecal incontinence, and non-obstructive urinary retention. Haessler told MD+DI that the InterStim device works very well but it's an expensive treatment and access is limited because only a few subspecialists in any one metropolitan area are truly qualified to deliver the therapy. The InterStim is not ...
Source: MDDI - April 19, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news